Publication Name	World Journal of Hepatology
Manuscript ID	118661
Country	Egypt

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt
Manuscript Source	Invited Manuscript
All Author List	Nahed A Makhlouf
Funding Agency and Grant Number
Corresponding Author	Nahed A Makhlouf, MD, Professor, Department of Tropical Medicine and Gastroenterology, Medical Director of Liver Transplantation Program, Al-Rajhi Liver Hospital, Faculty of Medicine, Assiut University, Assiut University Street, Assiut 71515, Egypt. nahedmak@yahoo.com
Key Words	Adolescents; Hepatitis C virus; Generic; Ledipasvir; Sofosbuvir; Treatment naïve; Treatment experienced; Egypt
Core Tip	Using brand forms of direct acting antivirals (DAAs) against hepatitis C virus (HCV) is limited in low- and middle-income countries. Generic forms of DAAs were widely used in adults. Few studies addressed this issue in children and adolescents in Egypt. We support the use of the generic forms of sofosbuvir/ledipasvir in HCV infected children and adolescents.
Citation	Makhlouf NA. Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt. World J Hepatol 2026; In press

Received	2026-01-21 02:03
Peer-Review Started	2026-01-21 05:37
First Decision by Editorial Office Director	2026-01-23 09:17
Return for Revision	2026-01-23 09:17
Revised	2026-01-28 18:19
Publication Fee Transferred
Second Decision by Editor	2026-02-05 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-02-05 09:27
Articles in Press	2026-02-05 09:27
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com